These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2553195)

  • 41. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
    Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
    Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Yoshioka T; Koide T; Okuyama A
    Urol Res; 1998; 26(3):209-13. PubMed ID: 9694604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.
    Berg C; Larsson L; Tiselius HG
    Urol Res; 1990; 18(1):13-6. PubMed ID: 2316066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
    Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
    [No Abstract]   [Full Text] [Related]  

  • 46. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of inhibitor deficiency in urolithiasis. II. Deficiency grade-adjusted and intermittent augmentation therapy for magnesium and citrate deficiency.
    Esen T; Akinci M; Tellaloğlu S; Koçak T
    Eur Urol; 1991; 19(3):244-8. PubMed ID: 1855531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of chondroitin sulfate, heparin sulfate, and citrate on Proteus mirabilis-induced struvite crystallization in vitro.
    McLean RJ; Downey J; Clapham L; Nickel JC
    J Urol; 1990 Nov; 144(5):1267-71. PubMed ID: 2122009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
    Lindberg J; Harvey J; Pak CY
    J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Int; 1983; 38(3):179-81. PubMed ID: 6868215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gel model for measuring crystallization inhibitor activity].
    Bothor C; Berg W; Börner RH; Jakob M
    Z Urol Nephrol; 1982 Oct; 75(10):689-98. PubMed ID: 6297185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Granulated potassium citrate in the prevention of calcium oxalate lithiasis].
    Campoy Martínez P; Arrabal Martín M; Quintero Rodríguez R; Espinosa Olmedo FJ; Castillo Gómez J; García Pérez M
    Actas Urol Esp; 1994 Feb; 18(2):101-5. PubMed ID: 7976691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnesium excretion and calcium oxalate urolithiasis.
    Resnick MI; Munday D; Boyce WH
    Urology; 1982 Oct; 20(4):385-9. PubMed ID: 7147507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.